Synthesis of a series of new 6-nitrobenzofuran-2-carbohydrazide derivatives with cytotoxic and antioxidant activity

• Published in: New Horizons in Translational Medicine
• Main Author: Taha M.; Sultan S.; Azlan M.; Shah S.A.A.; Jamil W.; Yeap S.K.; Imran S.; Akhtar M.N.; Zareen S.; Ismail N.H.; Ali M.
• Format: Article
• Language: English
• Published: Elsevier Ltd 2017
• Online Access: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85033730683&doi=10.1016%2fj.nhtm.2017.08.002&partnerID=40&md5=cbcc839d511c192c24ba05025df58bf6
• ISSN: 23075023
• DOI: 10.1016/j.nhtm.2017.08.002

6-nitrobenzofuran-2-carbohydrazide Schiff base derivatives have been synthesized and their structure has been confirmed via H1NMR, Mass spectrometry and elemental (CHN/S) analysis. These synthesized analogs showed significant cytotoxic and antioxidant activity. Doxorubicin (IC50 = 0.94 ± 0.20 μM) and n-propyl gallate (IC50 = 30.30 ± 0.40 μM) were used as standard in cytotoxic and antioxidant activities, respectively. Compound 1 (IC50 = 3.30 ± 0.90 μM), 2 (IC50 = 2.70 ± 0.25 μM), 3 (IC50 = 2.70 ± 0.25 μM), 10 (IC50 = 2.70 ± 1.10 μM), 11 (IC50 = 1.00 ± 1.20 μM), and 17 (IC50 = 3.75 ± 0.90 μM) showed excellent while 21 (IC50 = 7.50 ± 0.60 μM) and 28 (IC50 = 7.50 ± 0.66 μM) showed moderate anti cancer activity. Furthermore, compound 10 (IC50 = 17.50 ± 0.85 μM), 11 (IC50 = 24.20 ± 0.55 μM), 12 (IC50 = 21.10 ± 1.58 μM), 13 (IC50 = 14.60 ± 0.32 μM), 14 (IC50 = 29.20 ± 0.75 μM) and 15 (IC50 = 9.26 ± 0.15 μM) showed better antioxidant activity than the standard n-propyl gallate. This study will be useful to develop potential lead molecules with cytotoxic and antioxidant potential. © 2017 European Society for Translational Medicine